30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

PLx Pharma Inc (PLXP)

Track

Stock chart
Ticker: PLXP Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Giordano Natasha
Chief Executive Officer
1 purchase — total 14,977 USD
Buy 15 Mar 2022
Value US$1,479,234.81 | Price 422.58 | Shares 44,610
Buy 15 Mar 2022
Value US$1,682,226.19 | Price 379.51 | Shares 60,331
Buy 15 Mar 2022
Value US$4,191,242.17 | Price 483.99 | Shares 9,735
Buy 5 Mar 2021
Value US$200,000.00 | Price 8.00 | Shares 25,000
Buy 14 Dec 2020
Value US$2,195.96 | Price 5.49 | Shares 400
Buy 14 Dec 2020
Value US$3,252.00 | Price 5.42 | Shares 600
Buy 25 Nov 2020
Value US$2,737.85 | Price 5.48 | Shares 500
Buy 18 Nov 2020
Value US$1,003,176.30 | Price 3.79 | Shares 264,900
Buy 2 Sep 2020
Value US$8,126.60 | Price 3.83 | Shares 2,120
Buy 1 Sep 2020
Value US$16,837.20 | Price 3.74 | Shares 4,500
Buy 21 Aug 2020
Value US$16,090.65 | Price 3.97 | Shares 4,050
Buy 20 Aug 2020
Value US$8,665.71 | Price 3.77 | Shares 2,300
Buy 20 May 2019
Value US$248,662.40 | Price 5.60 | Shares 44,404
Buy 27 Dec 2018
Value US$397,495.00 | Price 1.00 | Shares 397,495
Buy 14 Jun 2017
Value US$50,001.88 | Price 6.88 | Shares 7,273
Buy 14 Jun 2017
Value US$200,000.62 | Price 6.88 | Shares 29,091
Buy 14 Jun 2017
Value US$224,998.12 | Price 6.88 | Shares 32,727
Buy 21 May 2014
Value US$27,000.00 | Price 9.00 | Shares 3,000
Buy 18 Mar 2014
Value US$24,000.00 | Price 12.00 | Shares 2,000
Buy 18 Mar 2014
Value US$24,996.00 | Price 12.00 | Shares 2,083
Buy 18 Mar 2014
Value US$24,996.00 | Price 12.00 | Shares 2,083
Buy 18 Mar 2014
Value US$24,996.00 | Price 12.00 | Shares 2,083
Buy 18 Mar 2014
Value US$24,996.00 | Price 12.00 | Shares 2,083
Buy 18 Mar 2014
Value US$24,996.00 | Price 12.00 | Shares 2,083
Buy 18 Mar 2014
Value US$6,000.00 | Price 12.00 | Shares 500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-03-16 2022-03-15 B Purchase
Giordano Natasha

Chief Executive Officer

Executive Director
44,610 -25.5%
422.58
US$1,479,235 		44,610 -25.5% 422.58 US$1,479,235
2022-03-16 2022-03-15 B Purchase
O'Connor Rita M

Chief Financial Officer

Officer
60,331 +4.3%
379.51
US$1,682,226 		60,331 +4.3% 379.51 US$1,682,226
2022-03-16 2022-03-15 B Purchase
O'Connor Rita M

Chief Financial Officer

Officer
9,735 -16.0%
483.99
US$4,191,242 		9,735 -16.0% 483.99 US$4,191,242
2021-03-09 2021-03-05 B Purchase
Valentino Michael J

Executive Chairman

Executive Director
25,000 +5.4%
8.00
US$200,000 		25,000 +5.4% 8.00 US$200,000
2020-12-15 2020-12-14 B Purchase
HADDEN JOHN
Non-Executive Director
400 +12.2%
5.49
US$2,196 		400 +12.2% 5.49 US$2,196
2020-12-15 2020-12-14 B Purchase
HADDEN JOHN
Non-Executive Director
600 +22.3%
5.42
US$3,252 		600 +22.3% 5.42 US$3,252
2020-11-25 2020-11-25 B Purchase
HADDEN JOHN
Non-Executive Director
500 +22.8%
5.48
US$2,738 		500 +22.8% 5.48 US$2,738
2020-11-20 2020-11-18 B Purchase
Valentino Michael J

Executive Chairman

Executive Director
264,900 +134.6%
3.79
US$1,003,176 		264,900 +134.6% 3.79 US$1,003,176
2020-09-03 2020-09-02 B Purchase
O'Connor Rita M

Chief Financial Officer

Officer
2,120 +19.5%
3.83
US$8,127 		2,120 +19.5% 3.83 US$8,127
2020-09-03 2020-09-01 B Purchase
O'Connor Rita M

Chief Financial Officer

Officer
4,500 +70.9%
3.74
US$16,837 		4,500 +70.9% 3.74 US$16,837
2020-08-24 2020-08-21 B Purchase
O'Connor Rita M

Chief Financial Officer

Officer
4,050 +176.1%
3.97
US$16,091 		4,050 +176.1% 3.97 US$16,091
2020-08-24 2020-08-20 B Purchase
O'Connor Rita M

Chief Financial Officer

Officer
2,300 +inf%
3.77
US$8,666 		2,300 +inf% 3.77 US$8,666
2019-05-21 2019-05-20 B Purchase
Valentino Michael J

Executive Chairman

Executive Director
44,404 +29.1%
5.60
US$248,662 		44,404 +29.1% 5.60 US$248,662
2018-12-31 2018-12-27 B Purchase Park West Asset Management LLC Large shareholder
397,495 +37.0%
1.00
US$397,495 		397,495 +37.0% 1.00 US$397,495
2017-06-16 2017-06-14 B Purchase MOSSMAN GARY L

Chief Operating Officer

Large shareholder
7,273 +10.2%
6.88
US$50,002 		7,273 +10.2% 6.88 US$50,002
2017-06-16 2017-06-14 B Purchase Valentino Michael J

Executive Chairman

Executive Director
29,091 +31.2%
6.88
US$200,001 		29,091 +31.2% 6.88 US$200,001
2017-06-16 2017-06-14 B Purchase JORDEN DAVID EMERSON

Acting Chief Financial Officer

Large shareholder
32,727 +27.5%
6.88
US$224,998 		32,727 +27.5% 6.88 US$224,998
2014-05-22 2014-05-21 B Purchase DEAN JACK H Non-Executive Director
3,000 +6.5%
9.00
US$27,000 		3,000 +6.5% 9.00 US$27,000
2014-03-20 2014-03-18 B Purchase HARRISON THOMAS L Non-Executive Director
2,000 +1.4%
12.00
US$24,000 		2,000 +1.4% 12.00 US$24,000
2014-03-20 2014-03-18 B Purchase DEAN JACK H Non-Executive Director
2,083 +4.8%
12.00
US$24,996 		2,083 +4.8% 12.00 US$24,996
2014-03-20 2014-03-18 B Purchase COUGHLIN CHRISTOPHER J Non-Executive Director
2,083 +1.9%
12.00
US$24,996 		2,083 +1.9% 12.00 US$24,996
2014-03-19 2014-03-18 B Purchase DELUCCIA ROBERT J

Executive Chairman

Executive Director Large shareholder
2,083 +0.1%
12.00
US$24,996 		2,083 +0.1% 12.00 US$24,996
2014-03-19 2014-03-18 B Purchase LUCI DAVID P

President, CEO, Secretary

Executive Director Large shareholder
2,083 +0.1%
12.00
US$24,996 		2,083 +0.1% 12.00 US$24,996
2014-03-19 2014-03-18 B Purchase Garrett David

VP, Finance & Corp. Dev.

Officer
2,083 +26.3%
12.00
US$24,996 		2,083 +26.3% 12.00 US$24,996
2014-03-19 2014-03-18 B Purchase Shawah Robert G.

Chief Accounting Officer

Officer
500 +inf%
12.00
US$6,000 		500 +inf% 12.00 US$6,000
Explore more

More insider trading research around PLx Pharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America